Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,565 | -3,277 | -944 | -5,259 | -4,463 |
| Depreciation Amortization | 291 | 195 | 114 | 201 | 323 |
| Other Working Capital | -543 | -385 | -19 | -408 | -101 |
| Other Operating Activity | 3,250 | 2,033 | 310 | 3,657 | 3,133 |
| Operating Cash Flow | $-1,567 | $-1,434 | $-540 | $-1,809 | $-1,107 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -1,939 | -666 | 0 | 0 | -457 |
| Investing Cash Flow | $-1,939 | $-666 | $N/A | $N/A | $-457 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 412 | 30 | N/A |
| Debt Issued | 159 | 9 | N/A | 342 | 282 |
| Debt Repayment | -277 | N/A | N/A | -327 | -179 |
| Common Stock Issued | 3,769 | 2,450 | N/A | 1,342 | 1,296 |
| Common Stock Repurchased | N/A | N/A | N/A | -7 | N/A |
| Other Financing Activity | -162 | -103 | 17 | 601 | 246 |
| Financing Cash Flow | $3,489 | $2,356 | $429 | $1,981 | $1,645 |
| Exchange Rate Effect | 8 | -44 | 7 | -25 | -28 |
| Beginning Cash Position | 864 | 864 | 864 | 717 | 717 |
| End Cash Position | 854 | 1,076 | 760 | 864 | 770 |
| Net Cash Flow | $-10 | $213 | $-104 | $147 | $53 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,567 | -1,434 | -540 | -1,809 | -1,107 |
| Free Cash Flow | -1,567 | -1,434 | -540 | -1,809 | -1,107 |